Conserved epitopes in human and mouse tissue-nonspecific alkaline phosphatase: Second report of the ISOBM TD-9 workshop

Tumor Biology

Volumn 26, Issue 3, 2005, Pages 113-120

  Narisawa, S ^a   Harmey, D ^a   Magnusson, P ^b   Millan J L ^a  

^a BURNHAM INSTITUTE   (United States)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Alkaline phosphatase; Bone; Epitope specificity; Immunoassays; Immunohistochemistry; Monoclonal antibodies; Western blot

Indexed keywords

ALKALINE PHOSPHATASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 314; MONOCLONAL ANTIBODY 315; MONOCLONAL ANTIBODY 333; MONOCLONAL ANTIBODY 334; UNCLASSIFIED DRUG; EPITOPE;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; CONFERENCE PAPER; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENZYME IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LONG BONE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; STAINING; WESTERN BLOTTING; ANIMAL; ARTICLE; COMPARATIVE STUDY; HUMAN; IMMUNOLOGY;

ALKALINE PHOSPHATASE; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; EPITOPES; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; MICE;

EID: 22844434167     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086482     Document Type: Conference Paper

References (57)

1. Magnusson P, Ärlestig L, Paus E, Di Mauro S, Testa MP, Stigbrand T, Farley JR, Nustad K, Millán JL: Monoclonal antibodies against bone alkaline phosphatase: The ISOBM TD-9 workshop. Tumor Biol 2002;23:228-248.
2. McComb RB, Bowers GN, Posen S: Alkaline Phosphatase. New York, Plenum Press, 1979.
3. Martin D, Tucker DF, Gorman PA, Sheer D, Spurr NK, Trowsdale J: The human placental alkaline phosphatase gene and related sequences map to chromosome 2 band q37. Ann Hum Gen 1987;51:145-152.
4. Harris H: The human alkaline phosphatases: What we know and what we don't know. Clin Chim Acta 1990;186:133-150.
5. Smith M, Weiss MJ, Griffin CA, Murray JC, Buetow KH, Emanuel BS, Henthorn PS, Harris H: Regional assignment of the gene for human liver/bone/kidney alkaline phosphatase to chromosome 1p36.1-p34. Genomics 1988;2:139-143.
6. Fishman WH: Perspectives on alkaline phosphatase isoenzymes. Am J Med 1974;56:617-650.
7. Kuwana T, Sugita O, Yakata M: Sugar chain heterogeneity of bone and liver alkaline phosphatase in serum. Enzyme 1991;45:63-66.
8. Nosjean O, Koyama I, Goseki M, Roux B, Komoda T: Human tissue non-specific alkaline phosphatases: Sugar-moiety-induced enzymic and antigenic modulations and genetic aspects. Biochem J 1997;321:297-303.
9. Magnusson P, Farley JR: Differences in sialic acid residues between bone alkaline phosphatase isoforms: A physical, biochemical and immunological characterization. Calcif Tissue Int 2002;71:508-518.
10. Farley JR, Baylink DJ: Skeletal alkaline phosphatase activity as a bone formation index in vitro. Metabolism 1986;35:563-571.
11. Van Straalen JP, Sanders E, Prummel MF, Sanders GTB: Bone-alkaline phosphatase as indicator of bone formation. Clin Chim Acta 1991;201:27-34.
12. Langman MJS, Leuthold E, Robson EB, Harris J, Luffman JE, Harris H: Influence of diet on the intestinal component of serum alkaline phosphatase in people of different ABO groups and secretor status. Nature 1966;212:41.
13. Kleerhoper M, Horne M, Cornish CJ, Posen S: Serum alkaline phosphatase after fat ingestion: An immunological study. Clin Sci 1970:38:339.
14. Boyer SH: Alkaline phosphatase in human serum and placentae. Science 1961;134:1002.
15. Fishman WH, Inglis NI, Green S, Antiss CL, Ghosh NK, Reif AE, Rustigan R, Krant MJ, Stolbach LL: Immunology and biochemistry of Regan isoenzyme of alkaline phosphatase in human cancer. Nature 1968;219:697.
16. Millán JL, Nustad K, Nørgaard-Pedersen B: Highly sensitive solid-phase immunoenzymometric assay for placental and placental-like alkaline phosphatases with a monoclonal antibody and monodisperse polymer particles. Clin Chem 1985;31:54-59.
17. Nouwen EJ, Buyssens N, De Broe ME: Heat-stable alkaline phosphatase as a marker for human and monkey type-I pneumocytes. Cell Tissue Res 1990;260:321-335.
18. Moss DW, Whitby LG: A simplified heat-inactivation method for investigating alkaline phosphatase isoenzymes in serum. Clin Chim Acta 1975;61:63-71.
19. Lin CW, Fishman WH: L-Homoarginine. An organ-specific, uncompetitive inhibitor of human liver and bone alkaline phosphohydrolases. J Biol Chem 1972;247:3082-3087.
20. Van Belle H: Alkaline phosphatase. 1. Kinetics and inhibition by levamisole of purified isoenzymes from humans. Clin Chem 1976;22:972-976.
21. Rosalki SB, Foo AY: Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem 1984;30:1182-1186.
22. Van Hoof VO, Lepoutre LG, Hoylaerts MF, Chevigné R, De Broe ME: Improved agarose electrophoretic method for separating alkaline phosphatase isoenzymes in serum. Clin Chem 1988;34:1857-1862.
23. Griffiths J, Black J: Separation and identification of alkaline phosphatase isoenzymes and isoforms in serum of healthy persons by isoelectric focusing. Clin Chem 1987;33:2171-2177.
24. Magnusson P, Löfman O, Larsson L: Determination of alkaline phosphatase isoenzymes in serum by high-performance liquid chromatography with post-column reaction detection. J Chromatogr 1992;576:79-86.
25. Magnusson P, Löfman O, Toss G, Larsson L: Determination of bone alkaline phosphatase isoforms in serum by a new high-performance liquid chromatography assay in patients with metabolic bone disease. Acta Orthop Scand 1995;66(suppl 266):203-204.
26. Magnusson P, Larsson L, Englund G, Larsson B, Strang P, Selin-Sjögren L: Differences of bone alkaline phosphatase isoforms in metastatic bone disease and discrepant effects of clodronate on different skeletal sites indicated by the location of pain. Clin Chem 1998;44:1621-1628.
27. Magnusson P, Larsson L, Magnusson M, Davie MWJ, Sharp CA: Isoforms of bone alkaline phosphatase: Characterization and origin in human trabecular and cortical bone. J Bone Miner Res 1999;14:1926-1933.
28. Bailyes EM, Seabrook RN, Calvin J, Maguire GA, Price CP, Siddle K, Luzio JP: The preparation of monoclonal antibodies to human bone and liver alkaline phosphatase and their use in immunoaffinity purification and in studying these enzymes when present in serum. Biochem J 1987;244:725-733.
29. Hill CS, Wolfert RL: The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase. Clin Chim Acta 1990;186:315-320.
30. Panigrahi K, Delmas PD, Singer F, Ryan W, Reiss O, Fisher R, Miller PD, Mizrahi I, Darte C, Kress BC, Christenson RH: Characteristics of a two-site immunoradiometric assay for human skeletal alkaline phosphatase in serum. Clin Chem 1994;40:822-828.
31. Gomez B Jr, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, Kung VT: Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 1995;41:1560-1566.
32. Broyles DL, Nielsen RG, Bussett EM, Lu WD, Mizrahi IA, Nunnelly PA, Ngo TA, Noell J, Christenson RH, Kress BC: Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase. Clin Chem 1998;44:2139-2147.
33. Kleerekoper M: Biochemical markers of bone remodeling. Am J Med Sci 1996;312:270-277.
34. Miller PD, Baran DT, Bilezikian JP, Greenspan SL, Lindsay R, Riggs BL, Watts NB: Practical clinical application of biochemical markers of bone turnover. J Clin Densitometry 1999;2:323-342.
35. Riggs BL: Are biochemical markers for bone turnover clinically useful for monitoring therapy in individual osteoporotic patients? Bone 2000;26:551-552.
36. Manes T, Glade K, Ziomek CA, Millán JL: Genomic structure and comparison of mouse tissue-specific alkaline phosphatase genes. Genomics 1990;8:541-554.
37. Waymire KG, Mahuren JD, Jaje JM, Guilarte TR, Coburn SP, MacGregor GR: Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nat Genet 1995;11:45-51.
38. Narisawa S, Fröhlander N, Millán JL: Inactivation of two mouse alkaline phosphatase genes and establishment of a mouse model of infantile hypophosphatasia. Dev Dyn 1997;208:432-446.
39. Fedde KN, Blair L, Silverstein J, Weinstein RS, Waymire K, MacGregor GR, Narisawa S, Millán JL, Whyte MP: Alkaline phosphatase knockout mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Min Res 1999;14:2015-2026.
40. Dehghani H, Narisawa S, Millán JL, Hahnel AC: Effects of disruption of the embryonic alkaline phosphatase gene on the preimplantation development of the mouse. Dev Dyn 2000;217:440-448.
41. Narisawa S, Huang L, Iwasaki A, Hasegawa H, Alpers DH, Millán JL: Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol Cell Biol 2003;23:7525-7530.
42. Narisawa S, Hofmann MC, Ziomek CA, Millán JL: Embryonic alkaline phosphatase is expressed at M-phase in the spermatogenic lineage of the mouse. Development 1992;116:159-165.
43. Hoshi K, Amizuka N, Oda K, Ikehara Y, Ozawa H: Immunolocalization of tissue non-specific alkaline phosphatase in mice. Histochem Cell Biol 1997;107:183-191.
44. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R: The in vitro development of blastocyst-derived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morp 1985;87:27-45.
45. Harmey D, Hessle L, Narisawa S, Johnson K, Terkeltaub R, Millán JL: Concerted regulation of inorganic pyrophosphate and osteopontin by Akp2, Enpp1 and Ank. An integrated model of the pathogenesis of mineralization disorders. Am J Pathol 2004;164:1199-1209.
46. Narisawa S, Hasegawa H, Watanabe K, Millán JL: Stage-specific expression of alkaline phosphatase during neural development in the mouse. Dev Dyn 1994;201:227-235.
47. Di Mauro S, Manes T, Hessle H, Kozlenkov A, Pizauro JM, Hoylaerts MF, Millán JL: Kinetic characterization of hypophosphatasia mutations with physiological substrates. J Bone Min Res 2002;17:1383-1391.
48. Le Du MH, Millán JL: Structural evidence of functional divergence in human alkaline phosphatases. J Biol Chem 2002;277:49808-49814.
49. Whyte MP: Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endo Rev 1994;15:439-461.
50. Mornet E, Stura E, Lia-Baldini AS, Stigbrand T, Menez A, Le Du MH: Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization. J Biol Chem 2001;276:31171-31178.
51. Bossi M, Hoylaerts MF, Millán JL: Modifications in a flexible surface loop modulate the isozyme-specific properties of mammalian alkaline phosphatases. J Biol Chem 1993;268:25409-25416.
52. Bruland Ø, Fodstad Ø, Funderud S, Pihl A: New monoclonal antibodies specific for human sarcomas. Int J Cancer 1986;38:27-31.
53. Deftos LJ, Wolfert RL, Hill CS: Bone alkaline phosphatase in Paget's disease. Horm Metab Res 1991;23:559-561.
54. Seabrook RN, Bailyes EM, Price CP, Siddle K, Luzio JP: The distinction of bone and liver isoenzymes of alkaline phosphatase in serum using a monoclonal antibody. Clin Chim Acta 1988;172:261-266.
55. Hata K, Tokuhiro H, Nakatsuka K, Miki T, Nishizawa Y, Morii H, Miura M: Measurement of bone-specific alkaline phosphatase by an immunoselective enzyme assay method. Ann Clin Biochem 1996;33:127-131.
56. Milligan TP, Park HR, Noonan K, Price CP: Assessment of the performance of a capture immunoassay for the bone isoform of alkaline phosphatase in serum. Clin Chim Acta 1997;263:165-175.
57. Hirano K, Matsumoto H, Tanaka T, Hayashi Y, Iino S, Domar D, Stigbrand T: Specific assays for human alkaline phosphatase isozymes. Clin Chim Acta 1987;166:265-273.